Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
26.56
-0.37 (-1.37%)
At close: May 30, 2025, 4:00 PM
26.52
-0.04 (-0.15%)
After-hours: May 30, 2025, 7:58 PM EDT
Moderna Revenue
Moderna had revenue of $108.00M in the quarter ending March 31, 2025, a decrease of -35.33%. This brings the company's revenue in the last twelve months to $3.18B, down -38.35% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.18B
Revenue Growth
-38.35%
P/S Ratio
3.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MRNA News
- 1 day ago - Moderna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call Transcript - Seeking Alpha
- 2 days ago - US cancels more $700 million funding for Moderna bird flu vaccine - Reuters
- 2 days ago - Moderna Announces Update on Investigational Pandemic Influenza Program - Accesswire
- 3 days ago - Moderna to Present at Upcoming Conferences in June 2025 - Accesswire
- 4 days ago - Will Moderna's Rally Continue? - Forbes
- 7 days ago - Moderna files application for updated COVID vaccine - Reuters
- 7 days ago - Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine - Accesswire
- 9 days ago - Moderna withdraws application for COVID-flu combination vaccine - Reuters